Delayed diagnosis, not gender affects women’s treatment for heart disease
Gender is not much of a factor in deciding whether women with heart disease should undergo the more complex multiple arterial revascularisation procedures that men receive, according to a new study published in The Annals of Thoracic Surgery. Instead, treatment is affected by factors such as delayed diagnosis of coronary artery disease (CAD) in women.
Using the Ottawa Heart Institute database, researchers analysed data from 19,557 patients who underwent coronary artery bypass grafting (CABG) between January 1990 and March 2015. Using 45 pretreatment variables, they narrowed the group to 1,254 patients (627 men and 627 women) who had similar characteristics so that they could test for differences between the two groups.
After correcting for various patient factors such as age, body weight, and diabetes, the researchers found no difference in the percentages of bilateral internal thoracic artery and radial artery use between men and women; the bilateral internal thoracic artery was used in 31.9% of men and 30.1% of women, while the radial artery was used in 44.5% of men and 44.1% of women. However, significantly fewer women received three arterial grafts when compared with men (7.3% vs. 10.5%).
“Most clinicians assume correctly that women are less likely to receive multiple arterial revascularisation, but they tend to believe that this is solely on the basis of a gender bias,” said senior author Fraser D. Rubens, MD, of the University of Ottawa Heart Institute in Canada. “The current study shows that gender does not play a significant role in this decision. There is no reason that, when adjusted for all risk factors, the degree of multiple arterial revascularisation in women should be any different than what men receive.”
In particular, women with CAD are at a significant disadvantage compared with men because they do not consistently receive the same intensive, invasive evaluation and treatment as men, the researchers pointed out. Men receive greater access to effective cardiac treatments, including medications and revascularisation, while women remain undiagnosed for many years. One reason for delayed diagnosis may be that current testing strategies, such as exercise treadmills, are “notoriously insensitive and nonspecific in women,” the researchers said.
Newer diagnostic tests, such as coronary computed tomography (CT) and myocardial perfusion imaging, may help doctors to better diagnose severe coronary disease in women, allowing for earlier and more complex interventions. In addition, the researchers pointed to a “protective effect” from oestrogen that may delay the onset of the disease.
“With earlier diagnoses, women could be referred for revascularisation as healthier surgical candidates, affording them the opportunity of complete arterial revascularisation strategies with better postoperative outcomes,” said Dr. Rubens. “This study has given us the confidence to continue educating surgeons on the feasibility of multiple arterial revascularisation and to ensure that this choice of surgical strategy be based on patient risk profiles and not solely on gender.”
Source: The Society of Thoracic Surgeons
Image Credit: Pixabay
Published on : Thu, 28 Sep 2017
CNAP® OEM partner solutions
The CNAP® technology is easily integrated into your product using our CNAP® OEM Partner Solutions.
INTEGRATION MADE EASY Discover our CNAP ® OEM partner solutions FULL SET OF NON-INVASIVE CONTINUOUS PATIENT SIGNALS Based on an easy-to-use dual finger sensor, the patented...
Hemodynamic measurement just got easier Task Force ® Touch CARDIO* provides a set of synchronized patient signals derived from the unique non-invasive CNAP ® finger sensor , combined with wireless 12-channel ECG. It is...
Continuous non-invasive blood pressure, cardiac output and fluid management for moderate and low-risk surgery CNAP ® Monitor provides advanced hemodynamic information from the non-invasive resusable CNAP ® finger sensor . It supports your Goal...
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...